A novel crosstalk between CCAR2 and AKT pathway in the regulation of cancer cell proliferation

Michela Restelli, Martina Magni, Vincenzo Ruscica, Patrizia Pinciroli, Loris De Cecco, Giacomo Buscemi, Domenico Delia, Laura Zannini

Research output: Contribution to journalArticle

Abstract

Human CCAR2 has recently emerged as having a pivotal role in the DNA damage response, promoting apoptosis and repair of heterochromatic DNA breaks. However, less is known about the function of CCAR2 in tumor formation and cancer progression. Here, we demonstrate, for the first time, that CCAR2 loss inhibits the proliferation of cancer cells, but preserves the growth of normal cells. Investigating the mechanisms responsible for this differential effect, we found that CCAR2 depletion specifically impairs the activation of AKT pathway in cancer cells, but not in normal cells, by reducing AKT phosphorylation on Ser473. This effect is achieved through the transcriptional upregulation of TRB3 gene and accumulation of TRB3 protein, which then binds to and inhibits the phosphorylation and activation of AKT. The defective activation of AKT finally results in reduced GSK3β phosphorylation, prevention of G1/S transition and inhibition of cancer cell growth. These results establish an important role for CCAR2 in cancer cells proliferation and could shed new light on novel therapeutic strategies against cancer, devoid of detrimental side effects.

Original languageEnglish
Pages (from-to)e2453
JournalCell Death and Disease
Volume7
Issue number11
DOIs
Publication statusPublished - Nov 3 2016

Fingerprint

Cell Proliferation
Neoplasms
Phosphorylation
DNA Breaks
Growth
DNA Damage
Up-Regulation
Apoptosis
Genes
Proteins
Therapeutics

Keywords

  • Journal Article

Cite this

A novel crosstalk between CCAR2 and AKT pathway in the regulation of cancer cell proliferation. / Restelli, Michela; Magni, Martina; Ruscica, Vincenzo; Pinciroli, Patrizia; De Cecco, Loris; Buscemi, Giacomo; Delia, Domenico; Zannini, Laura.

In: Cell Death and Disease, Vol. 7, No. 11, 03.11.2016, p. e2453.

Research output: Contribution to journalArticle

Restelli, Michela ; Magni, Martina ; Ruscica, Vincenzo ; Pinciroli, Patrizia ; De Cecco, Loris ; Buscemi, Giacomo ; Delia, Domenico ; Zannini, Laura. / A novel crosstalk between CCAR2 and AKT pathway in the regulation of cancer cell proliferation. In: Cell Death and Disease. 2016 ; Vol. 7, No. 11. pp. e2453.
@article{b56e5ec47c40484abda6dbf682ec8d9e,
title = "A novel crosstalk between CCAR2 and AKT pathway in the regulation of cancer cell proliferation",
abstract = "Human CCAR2 has recently emerged as having a pivotal role in the DNA damage response, promoting apoptosis and repair of heterochromatic DNA breaks. However, less is known about the function of CCAR2 in tumor formation and cancer progression. Here, we demonstrate, for the first time, that CCAR2 loss inhibits the proliferation of cancer cells, but preserves the growth of normal cells. Investigating the mechanisms responsible for this differential effect, we found that CCAR2 depletion specifically impairs the activation of AKT pathway in cancer cells, but not in normal cells, by reducing AKT phosphorylation on Ser473. This effect is achieved through the transcriptional upregulation of TRB3 gene and accumulation of TRB3 protein, which then binds to and inhibits the phosphorylation and activation of AKT. The defective activation of AKT finally results in reduced GSK3β phosphorylation, prevention of G1/S transition and inhibition of cancer cell growth. These results establish an important role for CCAR2 in cancer cells proliferation and could shed new light on novel therapeutic strategies against cancer, devoid of detrimental side effects.",
keywords = "Journal Article",
author = "Michela Restelli and Martina Magni and Vincenzo Ruscica and Patrizia Pinciroli and {De Cecco}, Loris and Giacomo Buscemi and Domenico Delia and Laura Zannini",
year = "2016",
month = "11",
day = "3",
doi = "10.1038/cddis.2016.359",
language = "English",
volume = "7",
pages = "e2453",
journal = "Cell Death and Disease",
issn = "2041-4889",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - A novel crosstalk between CCAR2 and AKT pathway in the regulation of cancer cell proliferation

AU - Restelli, Michela

AU - Magni, Martina

AU - Ruscica, Vincenzo

AU - Pinciroli, Patrizia

AU - De Cecco, Loris

AU - Buscemi, Giacomo

AU - Delia, Domenico

AU - Zannini, Laura

PY - 2016/11/3

Y1 - 2016/11/3

N2 - Human CCAR2 has recently emerged as having a pivotal role in the DNA damage response, promoting apoptosis and repair of heterochromatic DNA breaks. However, less is known about the function of CCAR2 in tumor formation and cancer progression. Here, we demonstrate, for the first time, that CCAR2 loss inhibits the proliferation of cancer cells, but preserves the growth of normal cells. Investigating the mechanisms responsible for this differential effect, we found that CCAR2 depletion specifically impairs the activation of AKT pathway in cancer cells, but not in normal cells, by reducing AKT phosphorylation on Ser473. This effect is achieved through the transcriptional upregulation of TRB3 gene and accumulation of TRB3 protein, which then binds to and inhibits the phosphorylation and activation of AKT. The defective activation of AKT finally results in reduced GSK3β phosphorylation, prevention of G1/S transition and inhibition of cancer cell growth. These results establish an important role for CCAR2 in cancer cells proliferation and could shed new light on novel therapeutic strategies against cancer, devoid of detrimental side effects.

AB - Human CCAR2 has recently emerged as having a pivotal role in the DNA damage response, promoting apoptosis and repair of heterochromatic DNA breaks. However, less is known about the function of CCAR2 in tumor formation and cancer progression. Here, we demonstrate, for the first time, that CCAR2 loss inhibits the proliferation of cancer cells, but preserves the growth of normal cells. Investigating the mechanisms responsible for this differential effect, we found that CCAR2 depletion specifically impairs the activation of AKT pathway in cancer cells, but not in normal cells, by reducing AKT phosphorylation on Ser473. This effect is achieved through the transcriptional upregulation of TRB3 gene and accumulation of TRB3 protein, which then binds to and inhibits the phosphorylation and activation of AKT. The defective activation of AKT finally results in reduced GSK3β phosphorylation, prevention of G1/S transition and inhibition of cancer cell growth. These results establish an important role for CCAR2 in cancer cells proliferation and could shed new light on novel therapeutic strategies against cancer, devoid of detrimental side effects.

KW - Journal Article

U2 - 10.1038/cddis.2016.359

DO - 10.1038/cddis.2016.359

M3 - Article

C2 - 27809307

VL - 7

SP - e2453

JO - Cell Death and Disease

JF - Cell Death and Disease

SN - 2041-4889

IS - 11

ER -